Abstract: Degradable polymeric compositions containing water-insoluble drugs blended with copolymers of biocompatible diphenol compound monomer units with pendant carboxylic acid groups polymerized with biocompatible diphenol com-pound monomer units with pendant carboxylic acid ester groups and poly(alkylene oxide) blocks, wherein the molar fraction in the copolymer of biocompatible diphenol compound monomer units with pendant carboxylic acid groups and poly(alkylene oxide) blocks relative to the weight percentage of the drug in the composition is effective to provide pseudo-zero order release of the drug from the composition during the sustained-release phase of drug delivery under physiological conditions. Ocular treatment methods and manufacturing methods are also disclosed.

Abstract: This invention provides detergent compositions, particularly liquid compositions, utilizing builders selected from the group consisting of a) polyether polycarboxylate compositions derived from polymers of furan/maleic anhydride copolymers; or b) polyether polycarboxylate compositions derived from polymers comprising furan, maleic anhydride and at least one copolymerized comonomer, selected from the group consisting of alkenyl alkyl ethers, alkyl acrylates, alkenyl carboxyalkyl ethers, vinyl esters of carboxylic acids, unsaturated carboxylic acids, unsaturated dicarboxylic acids and their anhydrides and esters, olefins and furan; c) polymers comprising furan, maleic anhydride, and at least one copolymerizable comonomer other than furan and maleic anhydride, which polymers may be intermediates in the production of the polyether polycarboxylate compositions by oxidation of the intermediate polymers; and d) combinations thereof.